drugset / Trial / NCT00631592
GSK1349572 Repeat Dose Escalation and Relative Bioavailability Study
NaSingle-groupDouble-blindTreatment
Summary
This is a repeat dose escalation study of GSK1349572 followed by a relative bioavailability study comparing tablet and suspension formulations in healthy volunteers.
Timeline
- Start
- 2008-02
- Primary completion
- 2008-06
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dolutegravir | Other / unclassified | — | — |
Indications
No indication recorded.